SCRA Technology Ventures Supports Charleston Startup
SBIR Phase I Matching Funds Awarded to Local Life Science Company
Summerville, SC - SCRA today announced that its SC Launch program has awarded Small Business Innovation Research (SBIR) Phase I matching funds for Charleston-based Tissue Testing Technologies. SC Launch awards matching funds to qualified SC Launch companies that have been granted federal SBIR Awards or Small Business Tech Transfer (STTR) Phase I Awards.
The company, led by CEO Dr. Kelvin Brockbank, a professor at both Clemson University and the Medical University of South Carolina, targets development of ice-free cryopreserved cell-based test systems that could replace animal testing and cryopreserved transplant innovations that could increase rates for successful tissue and organ transplants.
"We are delighted to support this innovative company," said SCRA CEO Bill Mahoney. "We look forward to the
advances that Tissue Testing Technologies will bring, and are proud to support them as a member of South Carolina's technology-based economy."
About SCRA Technology Ventures
SCRA Technology Ventures enables research commercialization and promotes the development of high tech industries, enhancing South Carolina's technology-based economy. Through its flagship SC Launch program, this SCRA business sector makes investments in and offers support services to South Carolina's early stage, start-up technology companies.
Multiple economic impact studies show SCRA's cumulative output on South Carolina's economy to be over $19.5 billion, and that the company has helped create approximately 15,000 technology-related jobs in the state, with annual wages averaging between $55,000 and $77,000.